Literature DB >> 23703297

Caloric restriction reduces edema and prolongs survival in a mouse glioma model.

Yong-Sheng Jiang1, Fu-Rong Wang.   

Abstract

Regardless of their cell type of origin, all aggressive brain tumors, such as malignant gliomas and metastatic tumors produce brain edema, which is an important cause of patient morbidity and mortality. Caloric restriction (CR) has long been recognized as a natural therapy that improves health, promotes longevity, and significantly reduces both the incidence and growth of many tumor types. The aim of present work was to investigate the effect of CR on edema and survival in the mice implanted with U87 gliomas. We found that CR significantly inhibited the intracerebral tumor growth, attenuated brain edema, and ultimately prolonged survival of mice with U87 gliomas. Plasma corticosterone level was found higher and serum VEGF and IGF-1 levels were found lower in CR, when compared to AL group. CR upregulated tight junction proteins including claudin-1, claudin-5 and ZO-1, downregulated VEGF and VEGFR2, enhanced α-SMA expression, and reduced AQP1 expression in U87 gliomas. In addition, CR suppressed inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) formation in U87 gliomas. In conclusion, CR attenuated edema in U87 orthotopic mouse glioma model associated with elevation of corticosterone, suppression of VEGF/VEGFR2, improvement of tight junctions, and suppression of iNOS expression and NO formation. Our results suggested that CR might be an effective therapy for recurrent malignant brain cancers through alleviating associated edema.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23703297     DOI: 10.1007/s11060-013-1154-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Immunohistochemical demonstration of serum proteins in human cerebral gliomas.

Authors:  R J Seitz; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

Authors:  S Oudard; E Boitier; L Miccoli; S Rousset; B Dutrillaux; M F Poupon
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

3.  Aquaporin-4 expression is increased in oedematous human brain tumours.

Authors:  S Saadoun; M C Papadopoulos; D C Davies; S Krishna; B A Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 4.  Emerging molecular mechanisms of brain tumour oedema.

Authors:  M C Papadopoulos; S Saadoun; D C Davies; B A Bell
Journal:  Br J Neurosurg       Date:  2001-04       Impact factor: 1.596

5.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

6.  Corticosteroid toxicity in neuro-oncology patients.

Authors:  D E Weissman; D Dufer; V Vogel; M D Abeloff
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 7.  Aquaporin water channels and brain edema.

Authors:  Marios C Papadopoulos; Sanjeev Krishna; A S Verkman
Journal:  Mt Sinai J Med       Date:  2002-09

8.  The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake.

Authors:  R Weindruch; R L Walford; S Fligiel; D Guthrie
Journal:  J Nutr       Date:  1986-04       Impact factor: 4.798

Review 9.  VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

Authors:  Elizabeth R Gerstner; Dan G Duda; Emmanuelle di Tomaso; Peter A Ryg; Jay S Loeffler; A Gregory Sorensen; Percy Ivy; Rakesh K Jain; Tracy T Batchelor
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

10.  Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Purna Mukherjee; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2010-07-23       Impact factor: 4.146

View more
  17 in total

Review 1.  The ketogenic diet for the treatment of malignant glioma.

Authors:  Eric C Woolf; Adrienne C Scheck
Journal:  J Lipid Res       Date:  2014-02-06       Impact factor: 5.922

Review 2.  Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches.

Authors:  Jeffrey M Politsky
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 3.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

4.  The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model.

Authors:  Eric C Woolf; Kara L Curley; Qingwei Liu; Gregory H Turner; Julie A Charlton; Mark C Preul; Adrienne C Scheck
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

5.  Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis.

Authors:  Mengmeng Lv; Xingya Zhu; Hao Wang; Feng Wang; Wenxian Guan
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

Review 6.  Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy.

Authors:  Eric C Woolf; Nelofer Syed; Adrienne C Scheck
Journal:  Front Mol Neurosci       Date:  2016-11-16       Impact factor: 5.639

Review 7.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 8.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

9.  The impact of dietary isoflavonoids on malignant brain tumors.

Authors:  Tina Sehm; Zheng Fan; Ruth Weiss; Marc Schwarz; Tobias Engelhorn; Nirjhar Hore; Arnd Doerfler; Michael Buchfelder; Iiker Y Eyüpoglu; Nic E Savaskan
Journal:  Cancer Med       Date:  2014-06-04       Impact factor: 4.452

10.  Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.

Authors:  Kirsty J Martin-McGill; Anthony G Marson; Catrin Tudur Smith; Michael D Jenkinson
Journal:  Pilot Feasibility Stud       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.